Acta Chimica Sinica ›› 2009, Vol. 67 ›› Issue (10): 1098-1102. Previous Articles     Next Articles

Original Articles

基于“底物包膜”假说筛选新型HIV-1蛋白酶抑制剂

缪有盼a 李爱秀*,a,b 刘 涛a 吴可柱a 马 翼c

  

  1. (a中国人民武装警察部队医学院基础医学部药物设计实验室 天津 300162)
    (b中国人民武装警察部队医学院职业与环境危害生物标志物天津市重点实验室 天津 300162)
    (c南开大学元素有机化学国家重点实验室 天津 300071)

  • 投稿日期:2008-11-14 修回日期:2008-12-31 发布日期:2009-05-28
  • 通讯作者: 李爱秀

Screening Novel HIV-1 Protease Inhibitors Based on the Substrate Envelope Hypothesis

Miao, Youpan a Li, Aixiu *,a,b Liu, Tao a Wu, Kezhu a Ma, Yi c   

  1. (a Drug Design Laboratory of the Basic Science Department, Medical College of Chinese People’s Armed Police Force,
    Tianjin 300162, China)
    (b Tianjin Key Laboratory for Biomarkers of Occupational and Environmental Hazard, Medical College of Chinese People’s
    Armed Police Force, Tianjin 300162, China)
    (c State Key Laboratory of Elemento-organic Chemistry, Nankai University, Tianjin 300071, China)
  • Received:2008-11-14 Revised:2008-12-31 Published:2009-05-28
  • Contact: Li, Aixiu

Based on the Substrate Envelope Hypothesis and the available HIV-1 protease inhibitor darunavir, a new pharmacophore model of HIV-1 protease inhibitors was constructed, and applied to the Traditional Chinese Medicine Database searching. By molecular docking, two compounds of novel structure that not only bind well with the HIV-1 protease, but also fit well within the substrate envelope, were found. They were annomonicin and desacetylbufotalin. Then molecular dynamics simulations were used to study these two compounds, which were complexed with HIV-1 protease in explicit water molecules. The structural stability and binding free energies were selected to evaluate these two compounds. With the hybrid method taking advantage of the synergistic effects of structure-based and ligand-based drug design techniques, the two new compounds were selected as the candidate compounds in this work. Through theory study and analysis, annomonicin is worthy of further study and research.

Key words: substrate envelope hypothesis, pharmacophore, molecular docking, molecular dynamics simulation, HIV-1 protease inhibitor